STAAR Surgical (STAA) has announced a board restructuring following the termination of its acquisition by Alcon. Neal C. Bradsher and Richard T. LeBuhn from Broadwood Partners, along with Christopher Wang from Yunqi Capital, have joined the board. Broadwood holds a 31% stake in STAAR. CEO Stephen Farrell and Chair Elizabeth Yeu have stepped down from the board, with Farrell remaining CEO until month-end. The board has expanded from six to seven members and plans to announce new leadership soon. STAAR shares dropped 3.3% following these developments.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.